ConductScience.org, home

Paper · 31754326

References60

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117284517Wound-induced ATP release and EGF receptor activation in epithelial cells.J Cell Sci2007https://conductscience.org/library/papers/17284517PubMed
223090120Purines, purinergic receptors, and cancer.Cancer Res2012https://conductscience.org/library/papers/23090120PubMed
316319112Pax 2/8-regulated Gata 3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney.Development2006https://conductscience.org/library/papers/16319112PubMed
430100605Notch3 inhibits epithelial-mesenchymal transition in breast cancer via a novel mechanism, upregulation of GATA-3 expression.Oncogenesis2018https://conductscience.org/library/papers/30100605PubMed
527321181Extracellular purines, purinergic receptors and tumor growth.Oncogene2017https://conductscience.org/library/papers/27321181PubMed
628472257Expression of Ecto-nucleoside Triphosphate Diphosphohydrolases-2 and -3 in the Enteric Nervous System Affects Inflammation in Experimental Colitis and Crohn's Disease.J Crohns Colitis2017https://conductscience.org/library/papers/28472257PubMed
725486274P2X7 mediates ATP-driven invasiveness in prostate cancer cells.PLoS One2014https://conductscience.org/library/papers/25486274PubMed
821642357Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}B.Carcinogenesis2011https://conductscience.org/library/papers/21642357PubMed
924828189Nucleotide signalling during inflammation.Nature2014https://conductscience.org/library/papers/24828189PubMed
1017603550Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases.Br J Pharmacol2007https://conductscience.org/library/papers/17603550PubMed
1130420446Targeting Purinergic Receptor P2Y2 Prevents the Growth of Pancreatic Ductal Adenocarcinoma by Inhibiting Cancer Cell Glycolysis.Clin Cancer Res2019https://conductscience.org/library/papers/30420446PubMed
1229733962Extracellular ATP drives breast cancer cell migration and metastasis via S100A4 production by cancer cells and fibroblasts.Cancer Lett2018https://conductscience.org/library/papers/29733962PubMed
1322174255Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice.Science2011https://conductscience.org/library/papers/22174255PubMed
1422555564Cellular function and molecular structure of ecto-nucleotidases.Purinergic Signal2012https://conductscience.org/library/papers/22555564PubMed
1516530853P2 receptors and cancer.Trends Pharmacol Sci2006https://conductscience.org/library/papers/16530853PubMed
1618575829Extracellular ATP and cancer: an overview with special reference to P2 purinergic receptors.Pathol Oncol Res2008https://conductscience.org/library/papers/18575829PubMed
1728683062Use of luciferase probes to measure ATP in living cells and animals.Nat Protoc2017https://conductscience.org/library/papers/28683062PubMed
1829027229Extracellular nucleosides and nucleotides as immunomodulators.Immunol Rev2017https://conductscience.org/library/papers/29027229PubMed
1925311278Deregulation of purine metabolism in Alzheimer's disease.Neurobiol Aging2015https://conductscience.org/library/papers/25311278PubMed
2023897954Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX.J Clin Oncol2013https://conductscience.org/library/papers/23897954PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/31754326/references